Calamos Advisors’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.08M | Buy |
69,207
+5,093
| +8% | +$374K | 0.02% | 528 |
|
|
2025
Q1 | $7.32M | Buy |
64,114
+24,788
| +63% | +$2.83M | 0.03% | 431 |
|
|
2024
Q4 | $1.98M | Sell |
39,326
-4,908
| -11% | -$247K | 0.01% | 575 |
|
|
2024
Q3 | $2.05M | Buy |
44,234
+32,755
| +285% | +$1.52M | 0.01% | 587 |
|
|
2024
Q2 | $373K | Buy |
+11,479
| New | +$373K | ﹤0.01% | 692 |
|